Trial Profile
A study to evaluate the prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Dec 2015
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms ISAR-SHOCK
- 29 Dec 2015 New trial record